Cardiovascular Diabetology

1. Cardiovasc Diabetol29 Sep 2023

   Association of triglyceride-glucose index trajectory and frailty in urban older residents: evidence from the 10-year follow-up in a cohort study

   Cohort study

2. Cardiovasc Diabetol29 Sep 2023

   Yearly attained adherence to Mediterranean diet and incidence of diabetes in a large randomized trial

   Secondary analysisT2D & other

3. Cardiovasc Diabetol27 Sep 2023

   Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals—a Swedish population-based study

   Cross-sectional studyT2D & other

4. Cardiovasc Diabetol21 Sep 2023

   Cumulative exposure to high remnant-cholesterol concentrations increases the risk of cardiovascular disease in patients with hypertension: a prospective cohort study

   Cohort studyLipids & liver

5. Cardiovasc Diabetol21 Sep 2023

   Subclinical left ventricular deformation and microvascular dysfunction in T2DM patients with and without peripheral neuropathy: assessed by 3.0 T cardiac magnetic resonance imaging

   Cohort studyT2D & other

6. Cardiovasc Diabetol21 Sep 2023

   Association between the atherogenic index of plasma and adverse long-term prognosis in patients diagnosed with chronic coronary syndrome

   Cohort study

7. Cardiovasc Diabetol16 Sep 2023

   Changes in the triglyceride glucose-body mass index estimate the risk of stroke in middle-aged and older Chinese adults: a nationwide prospective cohort study

   Cohort study

8. Cardiovasc Diabetol16 Sep 2023

   Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease

   Secondary analysisT2D & other

9. Cardiovasc Diabetol16 Sep 2023

   Plasma metabolite profiles associated with the World Cancer Research Fund/American Institute for Cancer Research lifestyle score and future risk of cardiovascular disease and type 2 diabetes

   Cross-sectional studyT2D & other

10. Cardiovasc Diabetol16 Sep 2023

    Temporal trends in chronic complications of diabetes by sex in community-based people with type 2 diabetes: the Fremantle Diabetes Study

    Cohort studyT2D & other

11. Cardiovasc Diabetol14 Sep 2023

    Serum branch-chained amino acids are increased in type 2 diabetes and associated with atherosclerotic cardiovascular disease

    Cross-sectional studyT2D & other

12. Cardiovasc Diabetol14 Sep 2023

    Inflammation and oxidative stress markers in type 2 diabetes patients with Advanced Carotid atherosclerosis

    Cross-sectional studyT2D & other

13. Cardiovasc Diabetol11 Sep 2023

    Unlocking the potential of microRNAs: machine learning identifies key biomarkers for myocardial infarction diagnosis

    Diagnostic or prognostic study

14. Cardiovasc Diabetol7 Sep 2023

    Endogenous estradiol contributes to vascular endothelial dysfunction in premenopausal women with type 1 diabetes

    Mechanistic studyT1D

15. Cardiovasc Diabetol7 Sep 2023

    Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium

    Cohort studyT2D & other

16. Cardiovasc Diabetol7 Sep 2023

    Triglyceride-glucose index and heart failure: a systematic review and meta-analysis

    Meta-analysisT2D & other

17. Cardiovasc Diabetol4 Sep 2023

    Ethnic differences in the association between age at diagnosis of diabetes and the risk of cardiovascular complications: a population-based cohort study

    Cohort studyT2D & other

18. Cardiovasc Diabetol4 Sep 2023

    Relationship between cumulative exposure to triglyceride-glucose index and heart failure: a prospective cohort study

    Cohort study

19. Cardiovasc Diabetol4 Sep 2023

    BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity

    Cross-sectional studyObesity

20. Cardiovasc Diabetol2 Sep 2023

    Association between the insulin resistance and all-cause mortality in patients with moderate and severe aortic stenosis: a retrospective cohort study

    Cohort study

21. Cardiovasc Diabetol2 Sep 2023

    Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies

    Meta-analysisT2D & other

22. Cardiovasc Diabetol1 Sep 2023

    Microvascular endothelial dysfunction in skin is associated with higher risk of heart failure with preserved ejection fraction in women with type 2 diabetes: the Hoorn Diabetes Care System Cohort

    Cross-sectional studyT2D & other

23. Cardiovasc Diabetol31 Aug 2023

    Sex-specific associations between adipokine profiles and carotid-intima media thickness in the Cameron County Hispanic Cohort (CCHC)

    Cross-sectional study

24. Cardiovasc Diabetol31 Aug 2023

    Association between the triglyceride glucose (TyG) index and the risk of acute kidney injury in critically ill patients with heart failure: analysis of the MIMIC-IV database

    Cohort study

25. Cardiovasc Diabetol31 Aug 2023

    Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia

    Cohort studyT2D & other

26. Cardiovasc Diabetol30 Aug 2023

    Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients without diabetes mellitus after coronary artery bypass grafting: a multicenter retrospective cohort study

    Cohort studyT2D & other

27. Cardiovasc Diabetol29 Aug 2023

    Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis

    Meta-analysisT2D & other

28. Cardiovasc Diabetol28 Aug 2023

    Association of prior outpatient diabetes screening with cardiovascular events and mortality among people with incident diabetes: a population-based cohort study

    Cohort studyT2D & other

29. Cardiovasc Diabetol26 Aug 2023

    Transitioning from having no metabolic abnormality nor obesity to metabolic impairment in a cohort of apparently healthy adults

    Cohort studyObesity

30. Cardiovasc Diabetol26 Aug 2023

    Insulin resistance estimated by estimated glucose disposal rate predicts outcomes in acute ischemic stroke patients

    Cohort study

31. Cardiovasc Diabetol24 Aug 2023

    Prognostic value of high-sensitivity C-reactive protein in patients undergoing percutaneous coronary intervention with different glycemic metabolism status

    Cohort studyComplications

32. Cardiovasc Diabetol24 Aug 2023

    Comprehensive transcriptomics and metabolomics analyses reveal that hyperhomocysteinemia is a high risk factor for coronary artery disease in a chinese obese population aged 40–65: a prospective cross-sectional study

    Cross-sectional studyObesity

33. Cardiovasc Diabetol24 Aug 2023

    Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis

    Meta-analysisT2D & other

34. Cardiovasc Diabetol24 Aug 2023

    Impact of early postoperative blood glucose variability on serum endocan level in cardiac surgery patients: a sub study of the ENDOLUNG observational study

    Secondary analysis

35. Cardiovasc Diabetol24 Aug 2023

    Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study

    Cohort studyT2D & other

36. Cardiovasc Diabetol24 Aug 2023

    Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project

    Cohort studyT2D & other

37. Cardiovasc Diabetol17 Aug 2023

    Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial

    Secondary analysisT2D & other

38. Cardiovasc Diabetol17 Aug 2023

    Clusters of prediabetes and type 2 diabetes stratify all-cause mortality in a cohort of participants undergoing invasive coronary diagnostics

    Cohort studyT2D & other

39. Cardiovasc Diabetol17 Aug 2023

    Association between fingertip-measured advanced glycation end products and cardiovascular events in outpatients with cardiovascular disease

    Cohort study

40. Cardiovasc Diabetol17 Aug 2023

    A six-month low-carbohydrate diet high in fat does not adversely affect endothelial function or markers of low-grade inflammation in patients with type 2 diabetes: an open-label randomized controlled trial

    Randomized controlled trialT2D & other

All 1,291 Briefs in ExploreShowing Briefs 1,081–1,120 of 1,291, newest first